• Cimetidine in H2 Antagonist Research: BBB Models to Cancer A

  2026-06-03

  Cimetidine stands apart as a histamine-2 receptor antagonist with partial agonist activity, enabling both advanced blood-brain barrier (BBB) modeling and robust antitumor research in gastrointestinal cancers. This article details protocol optimizations, troubleshooting, and the latest high-throughput workflows that leverage APExBIO’s high-purity Cimetidine for reproducibility and translational discovery.

• Syringin Targets EGFR/PI3K/Akt to Enhance Sunitinib in RCC

  2026-06-03

  A recent study demonstrates that Syringin, a natural product, inhibits renal cell carcinoma (RCC) cell proliferation and migration and enhances the efficacy of sunitinib by targeting the EGFR/PI3K/Akt pathway. These findings provide mechanistic insight into overcoming drug resistance in RCC and highlight new avenues for bioactive compound screening in cancer research.

• Etoposide (VP-16): Optimizing DNA Damage Assays in Cancer Re

  2026-06-02

  Etoposide (VP-16) is a gold-standard tool for inducing DNA double-strand breaks and apoptosis in cancer cell models, enabling highly quantitative DNA damage and cytotoxicity assays. This guide delivers actionable workflow enhancements, troubleshooting tips, and comparative insights for maximizing reproducibility and translational value in cancer chemotherapy research.

• Chlorpromazine HCl: Dopamine Receptor Antagonist for Researc

  2026-06-02

  Chlorpromazine HCl is a phenothiazine-class dopamine receptor antagonist widely used in neuropharmacology and cell biology research. Its robust receptor inhibition and solubility profile make it a standard tool for psychotic disorder and endocytosis studies. This article details its mechanisms, evidence, and workflow-critical parameters.

• CHI3L1-IN-5 (Z17): Bridging Neurodegeneration and Cardiac Re

  2026-06-01

  This thought-leadership article synthesizes the mechanistic and translational impact of CHI3L1-IN-5 (Compound Z17) as a dual-action modulator of neuroinflammation and myocardial injury. By integrating recent advances in selective CHI3L1 inhibition and triazole ALDH2 activation, we illuminate a new horizon for disease modeling, experimental design, and therapeutic strategy in complex CNS and cardiovascular disorders. Strategic protocol guidance and a critical discussion of cross-domain opportunities empower translational researchers to chart innovative, evidence-based research trajectories.

• Proteinase K: Broad-Spectrum Serine Protease for DNA Integri

  2026-06-01

  Proteinase K empowers high-fidelity DNA preparation by rapidly degrading proteins and enzymatic contaminants without compromising nucleic acid integrity. This article details actionable workflows, troubleshooting strategies, and cross-referenced innovations to maximize results in molecular biology labs.

• Cyanine 3 Tyramide: A Fluorescent Dye for Biomedical Researc

  2026-05-31

  Cyanine 3 Tyramide delivers robust signal amplification in demanding biomedical workflows, enabling high-resolution detection in neural circuit mapping and signaling studies. Its application in Tyramide Signal Amplification (TSA) offers researchers superior sensitivity, as showcased in recent oxytocin signaling research.

• MRT68921 ULK1 Kinase Inhibitor: Precision Autophagy Blockade

  2026-05-30

  MRT68921, a dual ULK1/2 kinase inhibitor from APExBIO, empowers researchers to dissect autophagy signaling with nanomolar precision. This article translates recent mechanistic advances into actionable workflows, troubleshooting strategies, and practical insights for advanced preclinical autophagy research.

• Triamcinolone Technical Guide: Solubility, Storage, and QC i

  2026-05-29

  Triamcinolone is a synthetic glucocorticoid agonist developed for controlled research on glucocorticoid receptor signaling, inflammation, and immunosuppression. Researchers should use this compound strictly for in vitro or ex vivo studies, as it is not intended for diagnostic or clinical applications. Proper handling of solubility and storage is crucial to ensure reproducible results.

• MRT68921: Precision ULK1 Kinase Inhibitor for Autophagy Anal

  2026-05-29

  MRT68921 offers nanomolar, dual ULK1/2 inhibition, enabling researchers to dissect autophagy initiation with high specificity. Its impact on ATG13 phosphorylation and LC3 flux sets a new standard for reproducible autophagy inhibition in preclinical research.

• HyperScribe T7 High Yield Cy3 RNA Labeling Kit: Advanced Pro

  2026-05-28

  The HyperScribe T7 High Yield Cy3 RNA Labeling Kit enables robust, customizable synthesis of fluorescent RNA probes for demanding applications like in situ hybridization and Northern blotting. Its optimized workflow balances high transcription yield with efficient Cy3-UTP incorporation, delivering superior sensitivity and reproducibility for RNA probe-based gene expression analysis.

• Reliable Cell Assays with EZ Cap™ Mouse IL-12 mRNA (m1Ψ)

  2026-05-28

  This article offers scenario-driven guidance for biomedical researchers seeking reproducible, high-sensitivity immune assays using EZ Cap™ Mouse IL-12 mRNA (m1Ψ) (SKU R1058). Drawing on quantitative evidence and practical workflow considerations, it demonstrates how this advanced mRNA reagent from APExBIO addresses common challenges in cell viability, proliferation, and cytotoxicity studies involving immune modulation.

• Wnt Agonist 1: Precision Tools for Translational Wnt Researc

  2026-05-27

  Explore how Wnt agonist 1 (BML-284) transforms canonical Wnt pathway research, enabling mechanistic insight and actionable guidance for translational scientists. This article integrates molecular rationale, experimental best practices, competitive context, and clinical relevance—highlighting APExBIO's advanced reagent and bridging mechanistic discovery with next-generation translational impact.

• Proteinase K: Broad-Spectrum Serine Protease for DNA Purity

  2026-05-27

  Proteinase K from APExBIO empowers reproducible DNA isolation by eliminating protein and nuclease contaminants without compromising genomic integrity. This article translates recent mechanistic insights and reference findings into actionable protocols and troubleshooting strategies for advanced molecular biology workflows.

• Batimastat (BB-94): Optimizing MMP Inhibition in Synaptic &

  2026-05-26

  Batimastat (BB-94) enables high-fidelity MMP inhibition across cancer and neuromuscular synapse studies with robust solubility and nanomolar potency. This guide translates recent breakthroughs in spatial BDNF processing and protocol design into actionable workflows for reproducible, high-impact results.

11370 records 1/758 page Next 12345 下5页 Last page